Anti-Integrin beta 1 antibody [RM1259]

The University of Nebraska Medical Center, a state agency operating under the Board of Regents of the University of Nebraska, awarded a purchase order to ABCAM INC for the procurement of laboratory research materials. The contract, issued on February 25, 2026, with a completion date of March 4, 2026, calls for the delivery of one unit of Anti-Integrin beta 1 antibody [RM1259] (material number ab322405-100uL), a specialized monoclonal antibody utilized in medical research and diagnostic applications. The contract value is $535.00, with the vendor located in Boston, Massachusetts, and the place of performance designated as the University of Nebraska Medical Center's Shipping and Receiving department at 601 South Saddle Creek Road, Omaha, Nebraska 68106.

The purchase order establishes standard commercial terms, including Net 30 payment conditions and Free on Board (F.O.B.) Destination basis with freight prepaid by the vendor. Delivery is scheduled for March 4, 2026, to unloading point BCC 8.12.416 Hingorani. ABCAM INC is required to acknowledge acceptance of the purchase order within ten days of issuance and ensure the purchase order number appears on all packages, invoices, and related documentation. The transaction is governed by the Standard Terms of Purchase established by the University of Nebraska.